Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Safiglipron

A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

Shandong Suncadia Medicine Co · Phase 1/2 · Completed · Enrollment 74

NCT06621316

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Treatment group An/rn/rn/rn/r
Treatment group Bn/rn/rn/rn/r
Treatment group Cn/rn/rn/rn/r
Treatment group Dn/rn/rn/rn/r
Treatment group En/rn/rn/rn/r
Treatment group Fn/rn/rn/rn/r
Treatment group Gn/rn/rn/rn/r
Treatment group Hn/rn/rn/rn/r
Treatment group In/rn/rn/rn/r
Treatment group Jn/rn/rn/rn/r
Treatment group Kn/rn/rn/rn/r
Treatment group Ln/rn/rn/rn/r

Not shown

  • Treatment group A: endpoint not reported
  • Treatment group B: endpoint not reported
  • Treatment group C: endpoint not reported
  • Treatment group D: endpoint not reported
  • Treatment group E: endpoint not reported
  • Treatment group F: endpoint not reported
  • Treatment group G: endpoint not reported
  • Treatment group H: endpoint not reported
  • Treatment group I: endpoint not reported
  • Treatment group J: endpoint not reported
  • Treatment group K: endpoint not reported
  • Treatment group L: endpoint not reported